---
figid: PMC7698403__cells-09-02494-g001
figtitle: Clinical pathway to metastatic castration resistant prostate cancer (mCRPC)
  with the current treatment options
organisms:
- NA
pmcid: PMC7698403
filename: cells-09-02494-g001.jpg
figlink: pmc/articles/PMC7698403/figure/cells-09-02494-f001/
number: F1
caption: Clinical pathway to metastatic castration resistant prostate cancer (mCRPC)
  with the current treatment options.
papertitle: Clinical Actionability of the Genomic Landscape of Metastatic Castration
  Resistant Prostate Cancer.
reftext: Wout Devlies, et al. Cells. 2020 Nov;9(11):2494.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7509046
figid_alias: PMC7698403__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC7698403__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7698403__cells-09-02494-g001.html
  '@type': Dataset
  description: Clinical pathway to metastatic castration resistant prostate cancer
    (mCRPC) with the current treatment options.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - enzalutamide
  - abiraterone
  - docetaxel
  - Abiraterone
  - cabazitaxel
  - Prostate Cancer
---
